REGENERX BIOPHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Operating Income (Loss) for the quarter ending March 31, 2023 was -$305K, a 11.3% increase year-over-year.
  • Regenerx Biopharmaceuticals Inc Operating Income (Loss) for the twelve months ending March 31, 2023 was -$1.36M, a 0.72% increase year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$1.4M, a 5.53% decline from 2021.
  • Regenerx Biopharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$1.33M, a 2.62% decline from 2020.
  • Regenerx Biopharmaceuticals Inc annual Operating Income (Loss) for 2020 was -$1.29M, a 2.59% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$1.36M -$305K +$38.9K +11.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$1.4M -$309K +$58.8K +16% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-11
Q3 2022 -$1.46M -$284K +$120K +29.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$1.58M -$465K -$207K -80.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 -$1.37M -$344K -$44.4K -14.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$1.33M -$368K -$76.9K -26.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-11
Q3 2021 -$1.25M -$404K -$124K -44.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.13M -$257K +$128K +33.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$1.26M -$299K +$38.7K +11.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$1.29M -$291K +$9.87K +3.28% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$1.3M -$280K +$6.04K +2.11% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.31M -$385K -$33.3K -9.46% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$1.28M -$338K -$15.3K -4.74% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$1.26M -$301K -$40.8K -15.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$1.22M -$286K +$70.8K +19.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$1.29M -$352K -$9.84K -2.88% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$1.28M -$323K +$41.3K +11.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$1.32M -$260K +$51.9K +16.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$1.38M -$357K +$84.9K +19.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1.46M -$342K -$39.1K -12.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$1.42M -$364K +$23.6K +6.08% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$1.44M -$312K +$33.6K +9.74% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$1.48M -$442K -$63.6K -16.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$1.41M -$303K +$195K +39.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$1.61M -$388K +$64.7K +14.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$1.67M -$345K +$37.6K +9.82% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$1.71M -$379K +$6.4K +1.66% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$1.72M -$498K +$53K +9.62% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$1.77M -$452K -$61.4K -15.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$1.71M -$383K -$10.9K -2.92% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 -$1.7M -$385K +$28.8K +6.97% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$1.73M -$551K -$145K -35.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-22
Q1 2015 -$1.58M -$391K -$27.4K -7.54% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$1.56M -$372K -$191K -106% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-11
Q3 2014 -$1.36M -$414K -$252K -156% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$1.11M -$406K -$160K -64.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$952K -$364K -$38.2K -11.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$914K -$181K -$88.6K -96.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$826K -$162K -$67.1K -71% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$759K -$246K -$20.8K -9.21% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$738K -$325K +$104K +24.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$841K -$92.2K +$771K +89.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-04
Q3 2012 -$1.61M -$94.5K +$1.92M +95.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 -$3.54M -$226K +$1.31M +85.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$4.84M -$429K +$1.17M +73.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$6.01M -$864K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-16
Q3 2011 -$2.02M -$428K -26.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$1.53M -$161K -11.7% Mar 31, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$1.59M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.37M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.